Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-021156

Controller/Prin Fin&Acct Offic bought 4,283 shares at $0.40 ($1,703)

From the SEC's structured data for this filing

Trades in this filing

Austin Mark John · Controller/Prin Fin&Acct Offic

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-16 Purchase : show line 1 in the form +4,283 $0.40 $1,703 16,000 D
Open-market purchases · 4,283 sh · avg $0.40 · $1,703
Loading xslF345X03/rdgdoc.xml…